Haemonetics Secures FDA Nod for VASCADE MVP XL Expansion
BOSTON, March 30, 2026 In a significant advancement for interventional cardiology and electrophysiology procedures, Haemonetics Corporation announced that the...
atrial fibrillation
Advertisement
OMNY AF Study Shows Early Gains in AF Ablation
Boston, Massachusetts — February 6, 2026 Johnson & Johnson has presented early clinical outcomes from the OMNY AF Pilot...
Field Medical Reports PULSE AF Study Data
SAN DIEGO, Feb. 2026 — Field Medical presented new clinical findings from its PULSE clinical study evaluating pulsed field...
HUYABIO Reports Positive Phase 1 Data for AF Drug HBI-3000
SAN DIEGO | January 6, 2026 — HUYABIO International has announced positive Phase 1 clinical results for HBI-3000, a...
FDA Approves Abbott Volt™ PFA System for Atrial Fibrillation
December 22, 2025 | Abbott Park, Illinois — Abbott announced that the U.S. Food and Drug Administration (FDA) has...
Advertisements
FDA Clears SANSA ECG for Arrhythmia Detection at Home
Atlanta, December 18, 2025 — Huxley Medical, Inc. announced that its SANSA® home sleep apnea test has received U.S....
Advertisement
